Expert develops successful start-up strategy for sites

October 2007
Clinical Trials Administrator;Oct2007, Vol. 5 Issue 10, p116
The article offers information on a strategy developed by clinical trials advisor Rita Viegas that showed significant improvements on the product development timeline over control sites that followed conventional practices. The strategy works by holding a prequalification teleconference, encouraging competitiveness among sites under consideration under study, creating a country-specific documentation tracking tool, keeping close phone contact with site staff, and providing additional training as needed.


Related Articles

  • News Update.  // Applied Clinical Trials;Jun2000, Vol. 9 Issue 6, p12 

    Reports on developments relating to clinical trial management as of June 2000. Inclusion of the United States Food and Drug Administration's approval of Novartis Pharmaceuticals Corp.'s Exelon, capsules for treating Alzheimer's disease; Phase 3 study of Sensus Drug Development Corp.'s use of...

  • Clinical Research and the Podiatrist. Alex, Michelle // Podiatry Management;Aug2010, Vol. 29 Issue 6, p183 

    The article focuses on the importance of clinical research in podiatric practice. Clinical trials evaluate new drugs and treatment methods, and each phase of a clinical trial helps researchers answer different questions. According to the article, conducting research can improve a podiatrist's...

  • Training for the Real World. Strack, Barry // Applied Clinical Trials;Mar2005, Vol. 14 Issue 3, p68 

    Focuses on the importance of the training of study coordinators in drug development and medical research in the U.S. Necessity for better training courses that will instruct and teach the theoretical and historical aspects of clinical research; Aspects of the coordinator training program;...

  • Searching for a Clinical Path Through the Fog of Statistics. Morrison, Trista // BioWorld Insight;11/2/2009, Vol. 17 Issue 44, p1 

    The article discusses the role of biostatistics in the clinical trial. It examines the impact of p-value standards in the development of drugs and towards chances to claim success in trials despite errors. Furthermore, it highlights the technical complexity and statistical penalty in the...

  • flowCore: a Bioconductor package for high throughput flow cytometry. Hahne, Florian; LeMeur, Nolwenn; Brinkman, Ryan R.; Ellis, Byron; Haaland, Perry; Sarkar, Deepayan; Spidlen, Josef; Strain, Errol; Gentleman, Robert // BMC Bioinformatics;2009, Vol. 10, Special section p1 

    Background: Recent advances in automation technologies have enabled the use of flow cytometry for high throughput screening, generating large complex data sets often in clinical trials or drug discovery settings. However, data management and data analysis methods have not advanced sufficiently...

  • Caution When Traveling Full Speed Ahead. Kaylynn Chiarello-Ebner // Pharmaceutical Technology;Jan2007, Vol. 31 Issue 1, p16 

    The author reflects on the implications of accelerated drug trials among pharmaceutical companies. She focuses on the disadvantage of the process wherein due to the being on fast track there is less time to scale up and fine tune the product, which is a key factor in drug development. She also...

  • Buoyant, but not booming. Shah, Apurva // BioSpectrum;Jun2012, Vol. 10 Issue 6, p26 

    The author discusses the slow growth of India's clinical trial market. He emphasizes the need of the Indian government to eliminate the aspects which hinder the growth of such market. He mentions the basis for the country to develop the required expertise in developing new drugs. He also...

  • Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital. Miho Watanabe; Soichiro Tajima; Katashima, Rumi; Toshiko Miyamoto; Makiko Yamagami; Kazuo Minakuchi; Hiroaki Yanagawa // BMC Research Notes;2014, Vol. 7 Issue 1, p2 

    Background Clinical trials leading to regulatory approval, or registration trials, play a central role in the development of drugs and medical devices. The contribution of support staff, such as the clinical research coordinator (CRC) and administrative officers, in registration trials is now...

  • Worldwide Clinial Trials Drug Development Solutions.  // Applied Clinical Trials;Dec2010, Vol. 19 Issue 12, p138 

    The article presents the corporate profile of Worldwide Clinical Trials Drug Development Solutions, a company which offers Phase I-IV clinical research services and bioanalytical sciences based in Austin, Texas. The company commits to cost-effective and highly efficient processes and methods. It...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics